Ciprofloxacin Hydrochloride News
Depomed to Announce Fourth Quarter and Year-End 2007 Financial ... - Earthtimes
Proquin ® XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated urinary ...
Depomed Names Abid Rawn Vice President of Sales and Marketing - Business Wire (press release)
ProQuin ® XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated urinary ...
Depomed Names Abid Rawn Vice President of Sales and Marketing - PharmaLive.com (press release)
ProQuin(R) XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated urinary ...
Market Review: Global Market Review for Depomed, Inc. - Trading Markets (press release)
ProQuin XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated urinary ...
Dutton Associates Announces Investment Opinion: Genesis Technology ... - Trading Markets (press release)
Laiyang Jiangbo's core products include clarithromycin sustained-release tablets, itopride hydrochloride granules, ciprofloxacin hydrochloride tablets, ...
depomed to present at the acumen biofin rodman & renshaw 9th ... - PharmaLive.com (press release)
... 2 diabetes and is being marketed in canada by biovail corporation. proquin(r) xr (ciprofloxacin hydrochloride) extended release tablets are approved in ...
Depomed Announces Retirement of Chief Financial Officer John F ... - Trading Markets (press release)
Proquin(R) XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated urinary ...
Depomed Announces Retirement of Chief Financial Officer John F ... - Trading Markets (press release)
Proquin(R) XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated urinary ...
Concur Technologies Prices Its 4.7 Mln Offering At $28.50 Per ... - RTT News
The companies specified that the ProQuin XR is a once-daily, extended-release formulation of ciprofloxacin hydrochloride for the treatment of uncomplicated ...
Marksans Pharma up on European nod for drug - Hindu Business Line
CHENNAI: Marksans Pharma shares gained on the BSE after the company said that it has received certificate of suitability for its ciprofloxacin hydrochloride ...
Ciprofloxacin Hydrochloride RSS Feed